RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer
0
조회
0
다운로드
0
인용
0
참고문헌
초록
5-Methylcytosine (m5C) is a common RNA modification that modulates gene expression at the posttranscriptional level, but the crosstalk between m5C RNA modification and biomolecule condensation, as well as transcription factor-mediated transcriptional regulation, in ovarian cancer, is poorly understood. In this study, we revealed that the RNA methyltransferase NSUN2 facilitates mRNA m5C modification and forms a positive feedback regulatory loop with the transcription factor E2F1 in ovarian cancer. Specifically, NSUN2 promotes m5C modification of E2F1 mRNA and increases its stability, and E2F1 binds to the NSUN2 promoter, subsequently reciprocally activating NSUN2 transcription. The RNA binding protein YBX1 functions as the m5C reader and is involved in NSUN2-mediated E2F1 regulation. m5C modification promotes YBX1 phase separation, which upregulates E2F1 expression. In ovarian cancer, NSUN2 and YBX1 are amplified and upregulated, and higher expression of NSUN2 and YBX1 predicts a worse prognosis for ovarian cancer patients. Moreover, E2F1 transcriptionally regulates the expression of the oncogenes MYBL2 and RAD54L, driving ovarian cancer progression. Thus, our study delineates a NSUN2-E2F1-NSUN2 loop regulated by m5C modification in a manner dependent on YBX1 phase separation, and this previously unidentified pathway could be a promising target for ovarian cancer treatment.
Abstract
5-Methylcytosine (m5C) is a common RNA modification that modulates gene expression at the posttranscriptional level, but the crosstalk between m5C RNA modification and biomolecule condensation, as well as transcription factor-mediated transcriptional regulation, in ovarian cancer, is poorly understood. In this study, we revealed that the RNA methyltransferase NSUN2 facilitates mRNA m5C modification and forms a positive feedback regulatory loop with the transcription factor E2F1 in ovarian cancer. Specifically, NSUN2 promotes m5C modification of E2F1 mRNA and increases its stability, and E2F1 binds to the NSUN2 promoter, subsequently reciprocally activating NSUN2 transcription. The RNA binding protein YBX1 functions as the m5C reader and is involved in NSUN2-mediated E2F1 regulation. m5C modification promotes YBX1 phase separation, which upregulates E2F1 expression. In ovarian cancer, NSUN2 and YBX1 are amplified and upregulated, and higher expression of NSUN2 and YBX1 predicts a worse prognosis for ovarian cancer patients. Moreover, E2F1 transcriptionally regulates the expression of the oncogenes MYBL2 and RAD54L, driving ovarian cancer progression. Thus, our study delineates a NSUN2-E2F1-NSUN2 loop regulated by m5C modification in a manner dependent on YBX1 phase separation, and this previously unidentified pathway could be a promising target for ovarian cancer treatment.
참고문헌 (59)
- Obermair, A., "Insights into ovarian cancer care : report from the ANZGOG Ovarian Cancer Webinar Series 2020", J. Gynecol. Oncol, 32, pp.e95~ (2021)
- Xia, C., "Cancer statistics in China and United States, 2022: profiles, trends, and determinants", Chin. Med. J. (Engl. ), 135, pp.584~590 (2022)
- Garrido, M. P., "Current treatments and new possible complementary therapies for epithelial ovarian cancer", Biomedicines, 10, pp.77~ (2021)
- Jayde, V., "Symptoms and diagnostic delay in ovarian cancer : a summary of the literature", Contemp. Nurse, 34, pp.55~65 (2009)
- Liu, T., "The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation", Nucleic Acids Res, 48, pp.3816~3831 (2020)
- Dai, Z., "N(7)-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression", Mol. Cell, 81, pp.3339~3355 (2021)
- Deng, L. J., "m6A modification : recent advances, anticancer targeted drug discovery and beyond", Mol. Cancer, 21, pp.52~ (2022)
- Xu, Y., "Role of main RNA methylation in hepatocellular carcinoma : N6Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine", Front. Cell Dev. Biol, 9, pp.767668~ (2021)
- Nombela, P., "The role of m(6)A, m(5)C and Psi RNA modifications in cancer : novel therapeutic opportunities", Mol. Cancer, 20, pp.18~ (2021)
- Jiang, X., "The role of m6A modification in the biological functions and diseases", Signal. Transduct. Target Ther, 6, pp.74~ (2021)
- Nie, S., "ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cis platin resistance in epithelial ovarian cancer", J. Exp. Clin. Cancer Res, 40, pp.284~ (2021)
- Muller, S., "IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A-and miRNA-dependent manner", Nucleic Acids Res, 47, pp.375~390 (2019)
- Li, J., "YTHDF2, a protein repressed by miR-145, reg ulates proliferation, apoptosis, and migration in ovarian cancer cells", J. Ovarian Res, 13, pp.111~ (2020)
- Hua, W., "METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition", Gynecol. Oncol, 151, pp.356~365 (2018)
- Trixl, L., "The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark", Wiley Interdiscip. Rev. RNA, 10, pp.e1510~ (2019)
- Huang, T., "Genome-wide identification of mRNA 5-methylcytosine in mammals", Nat. Struct. Mol. Biol, 26, pp.380~388 (2019)
- Heissenberger, C., "The ribosomal RNA m(5)C methyltransferase NSUN-1modulates healthspan and oogenesis in Caenorhabditis elegans", eLife, 9, pp.e56205~ (2020)
- Chellamuthu, A., "The RNA methyltransferase NSUN2 and its potential roles in cancer", Cells, 9, pp.1758~ (2020)
- Selmi, T., "Sequence-and structure-specific cytosine-5 mRNA methylation by NSUN6", Nucleic Acids Res, 49, pp.1006~1022 (2021)
- Xue, S., "Depletion of TRDMT1 affects 5-methylcytosine modification of mRNAandinhibits HEK293 cell proliferation and migration", Biochem. Biophys. Res. Commun, 520, pp.60~66 (2019)
- Yang, X., "5-methylcytosine promotes mRNA export-NSUN2 as the methyltransferase and ALYREF as an m(5)C reader", Cell Res, 27, pp.606~625 (2017)
- Chen, X., "5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs", Nat. Cell Biol, 21, pp.978~990 (2019)
- Sun, Z., "Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma", Oncogene, 39, pp.6906~6919 (2020)
- Liu, Y., "mRNA m5C controls adipogenesis by promoting CDKN1A mRNA export and translation", RNA Biol, 18, pp.711~721 (2021)
- Schumann, U., "Multiple links between 5-methylcytosine content of mRNA and translation", BMC Biol, 18, pp.40~ (2020)
- Su, J., "NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabi lization", Oncogene, 40, pp.5814~5828 (2021)
- Wang, J. Z., "The role of the HIF-1alpha", ALYREF, Cancer Commun. (Lond.), pp.2021, 41[DOI]
- Zhang, Q., "Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues", J. Transl. Med, 18, pp.245~ (2020)
- Van Nostrand, E., "Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP(eCLIP)", Nat. Methods, 13, pp.508~514 (2016)
- Rieder, D., "meRanTK : methylated RNA analysis ToolKit", Bioinformatics, 32, pp.782~785 (2016)
- Dobin, A., "STAR : ultrafast universal RNA-seq aligner", Bioinformatics, 29, pp.15~21 (2013)
- Huppert, T., "HomER: a review of time-series analysis methods for near-infrared spectroscopy of the brain", Appl. Opt, 48, pp.D280~D298 (2009)
- Ramírez, F., "deepTools2 : a next generation web server for deep-sequencing data analysis", Nucleic Acids Res, 44, pp.W160~W165 (2016)
- Liao, Y., "featureCounts : an efficient general purpose pro gram for assigning sequence reads to genomic features", Bioinformatics, 30, pp.923~930 (2014)
- Love, M., "Moderated estimation of fold change and dis persion for RNA-seq data with DESeq2", Genome Biol, 15, pp.550~ (2014)
- Yu, G., "clusterProfiler: an R package for comparing biological themes among gene clusters", OMICS, 16, pp.284~287 (2012)
- Zhang, H., "Integrated proteogenomic characterization of human high-grade serous ovarian cancer", Cell, 166, pp.755~765 (2016)
- Hu, Y., "Integrated proteomic and glycoproteomic characterization of human high-grade serous ovarian carcinoma", Cell Rep, 33, pp.108276~ (2020)
- Cheng, Y., "N(6)-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation", Cancer Cell, 39, pp.958~972 (2021)
- Liu, X. M., "Selective sorting of microRNAs into exosomes by phase-separated YBX1 condensates", eLife, 10, pp.e71982~ (2021)
- Wang, J., "Binding to m(6)A RNA promotes YTHDF2-mediated phase separation", Protein Cell, 11, pp.304~307 (2020)
- Guillén-Boixet, J., "RNA-induced conformational switching and clustering of G3BP drive stress granule assembly by condensation", Cell, 181, pp.346~361 (2020)
- Meng, P., "Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?", Cell Death Dis, 5, pp.e1360~ (2014)
- Bell, L. A., "Life and death decisions by E2F-1", Cell Death Differ, 11, pp.137~142 (2004)
- Nakajima, T., "Activation of B-Myb by E2F1 in hepatocellular carcinoma", Hepatol. Res, 38, pp.886~895 (2008)
- Hanada, N., "Co-regulation of B-Myb expression by E2F1 and EGF receptor", Mol. Carcinog, 45, pp.10~17 (2006)
- Mun, J. Y., "E2F1 promotes progression of bladder cancer by modulating RAD54L involved in homologous recombination repair", Int. J. Mol. Sci, 21, pp.9025~ (2020)
- Werwein, E., "Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis", trans isomerization, 2019, pp.47, 103~121
- Nathansen, J., "Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L", Oncogene, 40, pp.4214~4228 (2021)
- Xu, F., "FBW7 suppresses ovarian cancer development by targeting the N(6)methyladenosine binding protein YTHDF2", Mol. Cancer, 20, pp.45~ (2021)
- Li, H., "The identification of RNA modification gene PUS7 as a potential biomarker of ovarian cancer", Biology (Basel), 10, pp.807786~ (2021)
- Xu, J., "RNA 5-methylcytosine regulators contribute to metabolism hetero geneity and predict prognosis in ovarian cancer", Front. Cell Dev. Biol, 10, pp.807786~ (2022)
- Salditt-Georgieff, M., "Methyl labeling of HeLa cell hnRNA : a comparison with mRNA", Cell, 7, pp.227~237 (1976)
- Dubin, D. T., "The methylation state of poly A-containing-messenger RNA from cultured hamster cells", Nucleic Acids Res, 2, pp.1653~1668 (1975)
- Van Haute, L., "NSUN2 introduces 5-methylcytosines in mammalian mito chondrial tRNAs", Nucleic Acids Res, 47, pp.8720~8733 (2019)
- Amort, T., "Distinct 5-methylcytosine profiles in poly(A)RNA from mouse embryonic stem cells and brain", Genome Biol, 18, pp.1~ (2017)
- Zou, F., "Drosophila YBX1 homolog YPS promotes ovarian germ line stem cell development by preferentially recognizing 5-methylcytosine RNAs", Proc. Natl. Acad. Sci. USA, 117, pp.3603~3609 (2020)
- Zhang, X., "The tRNA methyltransferase NSun2 stabilizes p16INK(4)mRNA by methylating the 3′-untranslated region of p16", Nat. Commun, 3, pp.712~ (2012)
- Mei, L., "RNA methyltransferase NSUN2 promotes gastric cancer cell pro liferation by repressing p57(Kip2)by an m(5)C-dependent manner", Cell Death Dis, 11, pp.270~ (2020)
